Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
J Biol Chem. 2011 Jan 21;286(3):1828-35. doi: 10.1074/jbc.M110.160390. Epub 2010 Nov 17.
The Ca(2+)-sensing receptor (CaR) regulates salt and water transport in the kidney as demonstrated by the association of gain of function CaR mutations with a Bartter syndrome-like, salt-wasting phenotype, but the precise mechanism for this effect is not fully established. We found previously that the CaR interacts with and inactivates an inwardly rectifying K(+) channel, Kir4.1, which is expressed in the distal nephron that contributes to the basolateral K(+) conductance, and in which loss of function mutations are associated with a complex phenotype that includes renal salt wasting. We now find that CaR inactivates Kir4.1 by reducing its cell surface expression. Mutant CaRs reduced Kir4.1 cell surface expression and current density in HEK-293 cells in proportion to their signaling activity. Mutant, activated Gα(q) reduced cell surface expression and current density of Kir4.1, and these effects were blocked by RGS4, a protein that blocks signaling via Gα(i) and Gα(q). Other α subunits had insignificant effects. Knockdown of caveolin-1 blocked the effect of Gα(q) on Kir4.1, whereas knockdown of the clathrin heavy chain had no effect. CaR had no comparable effect on the renal outer medullary K(+) channel, an apical membrane distal nephron K(+) channel that is internalized by clathrin-coated vesicles. Co-immunoprecipitation studies showed that the CaR and Kir4.1 physically associate with caveolin-1 in HEK cells and in kidney extracts. Thus, the CaR decreases cell surface expression of Kir4.1 channels via a mechanism that involves Gα(q) and caveolin. These results provide a novel molecular basis for the inhibition of renal NaCl transport by the CaR.
钙敏感受体(CaR)调节肾脏中的盐和水转运,这一点已被功能获得性 CaR 突变与 Bartter 综合征样盐耗竭表型相关联所证明,但这种作用的确切机制尚未完全确立。我们先前发现,CaR 与内向整流钾(K+)通道 Kir4.1 相互作用并使其失活,Kir4.1 表达于远端肾单位,有助于基底外侧 K+电导,而功能丧失性突变与包括肾盐耗竭在内的复杂表型相关联。我们现在发现,CaR 通过减少 Kir4.1 的细胞表面表达来使其失活。突变型 CaR 使 Kir4.1 的细胞表面表达和电流密度成比例地降低,与它们的信号活性成比例。突变的、激活的 Gα(q) 降低了 Kir4.1 的细胞表面表达和电流密度,并且这些效应被 RGS4 阻断,RGS4 是一种通过 Gα(i) 和 Gα(q) 阻断信号转导的蛋白。其他α亚基没有显著影响。敲低 caveolin-1 阻断了 Gα(q) 对 Kir4.1 的作用,而敲低 clathrin 重链则没有影响。CaR 对肾脏外髓质 K+通道(一种顶端膜远端肾单位 K+通道,通过网格蛋白包被小泡内化)没有类似的作用。共免疫沉淀研究表明,CaR 和 Kir4.1 在 HEK 细胞和肾脏提取物中与 caveolin-1 物理结合。因此,CaR 通过涉及 Gα(q) 和 caveolin 的机制降低 Kir4.1 通道的细胞表面表达。这些结果为 CaR 抑制肾 NaCl 转运提供了新的分子基础。